Dr. Barzilai is a longevity physician and Lecturer at Harvard Medical School, and a founding faculty member and Trustee of the Geneva College of Longevity Science, where he helps shape the emerging field of longevity medicine. Holding an MD, PhD, and MBA, and board-certified as a Diplomate of the American Board of Lifestyle Medicine, he integrates clinical expertise with biomarker analytics, precision protocols, and performance-focused interventions across cardiovascular, metabolic, cognitive, musculoskeletal, and preventive health. A scientific and strategic advisor and frequent keynote speaker in the longevity and health-tech sectors, he is known for translating complex scientific advances into clear, actionable strategies. He is the CEO of Barzilai Longevity Consulting and the physician behind Agingdoc.com, delivering personalized longevity guidance for individuals, executives, and organizations seeking to extend and optimize healthspan.

At the beginning of his career, Kevin worked for Swiss Re in the large corporate direct insurance division called Swiss Re Corporate Solutions. A personal incident of medical malpractice has made him find his purpose in health management. Today, Kevin is the CEO at SIP Medical Family Office. For over 25 years, individuals, families, and companies have been relying on SIP’s expertise to protect their health around the world. Founded as an International Private Medical Insurance advisor, SIP has developed into what is today known as a Medical Family Office. Combining the expertise from private medical insurance with a holistic approach towards proactively planning one’s health, it has been SIP’s mission to protect people’s health since 1997.

While International Private Medical Insurance remains an important focus, SIP has developed a Medical Concierge proposition to plan people’s health strategically and ensure better outcomes in acute situations. This ranges from Privileged Healthcare to Preventive Medicine, Longevity, Medical Records Management, and more. 

Dr Sabine Donnai is an international leader in proactive health management and a highly regarded Harley Street consulting general physician. As the founder and chief executive of Viavi, she has led the development of advanced health strategy services for healthy longevity, combining advanced technology, cutting edge science, and an integrated, holistic approach. Sabine appears frequently in the media as well as delivering thought-leadership events. Most recently she was featured in the Financial Times discussing Viavi’s work in improving resilience and energy within her C suite clients. Viavi was described by Bloomberg as one of the most comprehensive healthspan services globally. Sabine sits on the international expert advisory board on the prevention of Alzheimers.

Chantal joined SIP Medical Family Office as a Client Advisor in April 2024. As an independent intermediary, specialising in Private Clients and SMEs, she has over 11 years’ experience in the industry looking at both International Private Medical Insurance as well as domestic UK PMI.

Todd McAllister, PhD, is widely regarded as one of the original architects of Longevity Medicine and a leading visionary in the transformation of modern healthcare. A scientist, entrepreneur, and systems thinker, his work has helped shift medicine from a reactive, disease-centered model to a proactive, data-driven discipline focused on extending healthspan, performance, and functional longevity. Over the past 25 years, Dr. McAllister has founded, scaled, and advised companies at the forefront of preventive and regenerative healthcare. He was the co-founder and CEO of Fountain Life, alongside Tony Robbins and Peter Diamandis—one of the first companies globally to focus explicitly on proactive, prevention-based care rather than episodic disease treatment. At Fountain Life, Dr. McAllister designed and operationalized what has become the foundational clinical framework for longevity medicine, organizing care around three core pillars: Precision Diagnostics, Performance Optimization, and Advanced Therapeutics. This integrated model established the clinical focus on healthspan over lifespan and continues to define the approach used by longevity clinics worldwide. Following Fountain Life, Dr. McAllister partnered with ProMedica Health System, the 14th largest healthcare system in the United States, to build and operate the Icaria Longevity Center. This initiative embedded proactive longevity care within a traditional primary care environment, demonstrating how advanced prevention models could scale within large healthcare systems and helping bring longevity medicine closer to the mainstream. Dr. McAllister also brings exceptional scientific credibility to the field. His pioneering work in cell-based therapies was recognized by Scientific American as one of the Top 50 achievements in science, business, and policy, and he is a two-time finalist for the NIH Pioneer Award. His research has been widely published in top-tier journals, including The New England Journal of Medicine, Lancet, Nature Medicine, and Science, contributing to the clinical understanding of regenerative therapies, translational medicine, and the biology of aging. Most recently Dr. McAllister co-founded Skai Health, a network of concierge primary care clinics in the UK and Middle East. As Skai’s Founding Scientist, he continues his mission to translate complex biological data into clear, actionable care—turning early insight into lasting health.

Edouard specializes in the purchase, sale of trophy assets, with a strong expertise in, construction, financing, chartering and registration of large yachts and vessels. He advises numerous stakeholders in the maritime industry and in the field of exceptional assets, both in France and internationally, and has significant experience in international business law and contract law.

Currently Vice-President of the Monaco Yachting Cluster, he is convinced that certain exceptional assets represent genuine vehicles for transmission.

Edouard has a particular interest in the concept of Family Longevity. His presentation will explore how the acquisition and structuring of assets — such as exceptional properties, art collections… — can become true “legacy assets”, reflect a lifestyle and foster harmonious transmission between generations.

Dr. Damien Ng is a Senior Thematic Research Analyst at Julius Baer, specialising in demographics, longevity, and well-being. He holds a PhD from Durham University and brings global experience from roles at Goldman Sachs and Reuters. A published author and sought-after speaker, Ng frequently presents at Julius Baer, universities, and external events, sharing insights at the intersection of finance and healthcare.

Philip Nitschke is the Founder of Exit International, an international non profit organisation which advocates for the fundamental human right of every rational adult over a certain age to make their own end of life decisions.

In 1997, Philip became the first doctor in the world to help four terminally ill patients to die under Australia’s short-lived Rights of the Terminally Ill Act.

For the past 2 decades, Philip has been the lead author of the Peaceful Pill Handbook, which is the leading guide on practical end of life choices.

He is also the inventor of a range of end of life devices such as the Deliverance Machine (British Science Museum) and the 3D-printed Sarco device which was first used by a serious ill American woman in Switzerland in September 2024.

Philip holds a PhD in applied physics from Flinders University in Adelaide and is a graduate of Sydney Medical School.

Marios Rafail is the Head of the Geneva office and an Executive Director Private Clients at Henley & Partners. He is also the Key Intermediaries Manager of Henley & Partners Switzerland AG, representing the firm in the Swiss–Francophone region. Marios is responsible for the business development function of the company and possesses a thorough knowledge of the key residence and citizenship programs.

Prior to joining Henley & Partners Switzerland AG, Marios headed the finance department of a family office out of China and Greece and has worked for Mesirow Financial Consulting out of Chicago, US in the corporate advisory team, and Bloomberg, LLP in the sales management team.

Marios holds a master's degree from Brandeis University in International Finance and Accounting, and he speaks six languages.

Corinne is a tax expert with particular know-how on a range of international tax matters affecting private clients in respect of their investments, business projects and estate planning.

She has acquired extensive expertise in advising on pre-immigration tax planning for new Monaco residents, notably on the reorganization of foreign holding structures owning Monaco or French real estate assets, as well as succession planning during Monaco residence.
Corinne further has a strong practice of cross-border transactional tax law. She advises successful entrepreneurs on group reorganizations, including the negotiation of tax rulings before the tax authorities.

Committed to the challenges of Family Longevity, Corinne will focus on succession planning issues, the pitfalls to avoid and the management of conflicts of laws in order to secure the transmission of family wealth.

Xavier is recognized as an international expert on Family Governance matters. Author of several articles on the subject, he regularly speaks at international conferences and forums. 

He is an expert in succession and estate planning, as well as asset protection mechanisms, and he serves as Director, Trustee or Protector of several family or private groups, based in Europe, US and Asia.

Through his involvement in the setting up and management of sophisticated Private Client structures he has acquired a unique hands-on experience of such organizations.

Deeply committed to the concept of Family Longevity, Xavier will address the way in which an appropriate organization can ensure proper longevity of a family and the sustainable transmission of its assets, by combining sound governance, protection and an intergenerational vision.